Skip to Main Content

Paper Details

Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
J Clin Oncol
44
2022
BC, Circulating Tumor DNA, HR, Hormone Receptor, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer, Human Epidermal Growth Factor Receptor 2, MRD, Patients, breast cancer, circulating, circulating tumor DNA, ctDNA, patient, patients, plasma, primary, tumor, variants
Author NameAffiliation
Sara M TolaneyDana-Farber Cancer Institute
Sara M TolaneyHarvard Medical School
Ian E KropDana-Farber Cancer Institute
Ian E KropPresent affiliation: Yale University
Ian E KropHarvard Medical School
Eric P WinerDana-Farber Cancer Institute
Eric P WinerHarvard Medical School
Eric P WinerPresent affiliation: Yale University
Nancy U LinDana-Farber Cancer Institute
Nancy U LinHarvard Medical School
  • 1 - 10

Datasets

Release 1.2